Table 1.
Variables | Total, No. (%) | Non-NAC, No. (%) | NAC, No. (%) | P value |
---|---|---|---|---|
Age, yr (median, IQR) | 68 (61, 75) | 69 (61, 75) | 67 (59, 72) | .073 |
Age, yr | .224 | |||
≤70 | 750 (59.1%) | 700 (58.7%) | 50 (65.8%) | |
>70 | 518 (40.9%) | 492 (41.3%) | 26 (34.2%) | |
Sex | .418 | |||
Male | 1029 (81.2%) | 970 (81.4%) | 59 (77.6%) | |
Female | 239 (18.8%) | 222 (18.6%) | 17 (22.4%) | |
Race | .121 | |||
White | 1134 (89.4%) | 1062 (89.1%) | 72 (94.7%) | |
Other | 134 (10.6%) | 130 (10.9%) | 4 (5.3%) | |
N stage | <.001 | |||
N0 | 1237 (97.6%) | 1168 (98.0%) | 69 (90.8%) | |
N+ | 31 (2.4%) | 24 (2.0%) | 7 (9.2%) | |
Size, mm | .779 | |||
<30 | 335 (26.4%) | 316 (26.5%) | 19 (25%) | |
≥30 | 348 (27.4%) | 329 (27.6%) | 19 (25%) | |
Unknown | 585 (46.1%) | 547 (45.9%) | 38 (50%) | |
Histology | .009 | |||
Urothelial | 1206 (95.1%) | 1139 (95.6%) | 67 (88.2%) | |
Non-urothelial | 62 (4.9%) | 53 (4.4%) | 9 (11.8%) |
IQR = interquartile range, NAC = neoadjuvant chemotherapy.